TTM
$49.37B
YoY change
+9.7%
5Y CAGR
+17.7%
Peak year (2025)
$48.11B
Cumulative gross profit
$642.29B
Gross Profit history chart for AstraZeneca (AZN) from 1990 to 2025
Latest: $48.11B
Gross Profit growth chart for AstraZeneca (AZN) from 1990 to 2025
Latest: +9.7%
Gross Profit history table for AstraZeneca (AZN) from 1990 to 2025
| 2025 | $48.11B | +9.7% | +$4.24B | ||
| 2024 | $43.87B | +16.8% | +$6.32B | ||
| 2023 | $37.54B | +17.5% | +$5.58B | ||
| 2022 | $31.96B | +27.9% | +$6.98B | ||
| 2021 | $24.98B | +17.2% | +$3.66B | ||
| 2020 | $21.32B | +9.5% | +$1.85B | ||
| 2019 | $19.46B | +13.5% | +$2.31B | ||
| 2018 | $17.15B | -5.5% | −$993.00M | ||
| 2017 | $18.15B | -3.9% | −$729.00M | ||
| 2016 | $18.88B | -5.9% | −$1.19B | ||
| 2015 | $20.06B | -3.1% | −$643.00M | ||
| 2014 | $20.70B | +0.8% | +$160.00M | ||
| 2013 | $20.55B | -9.0% | −$2.04B | ||
| 2012 | $22.58B | -18.1% | −$4.99B | ||
| 2011 | $27.57B | +2.5% | +$685.00M | ||
| 2010 | $26.88B | -0.6% | −$149.00M | ||
| 2009 | $27.03B | +8.1% | +$2.03B | ||
| 2008 | $25.00B | +8.1% | +$1.86B | ||
| 2007 | $23.14B | +10.6% | +$2.22B | ||
| 2006 | $20.92B | +12.5% | +$2.32B | ||
| 2005 | $18.59B | +14.5% | +$2.36B | ||
| 2004 | $16.23B | +12.8% | +$1.85B | ||
| 2003 | $14.39B | +8.0% | +$1.06B | ||
| 2002 | $13.32B | +10.8% | +$1.30B | ||
| 2001 | $12.02B | -33.6% | −$6.09B | ||
| 2000 | $18.12B | +52.4% | +$6.23B | ||
| 1999 | $11.89B | +28.0% | +$2.60B | ||
| 1998 | $9.29B | — | +$9.29B | ||
| 1997 | $0.00 | — | $0.00 | ||
| 1996 | $0.00 | — | $0.00 | ||
| 1995 | $0.00 | — | $0.00 | ||
| 1994 | $0.00 | — | $0.00 | ||
| 1993 | $0.00 | — | $0.00 | ||
| 1992 | $0.00 | — | $0.00 | ||
| 1991 | $0.00 | — | $0.00 | ||
| 1990 | $0.00 | — | — |
- 2025$48.11B+9.7%
- 2024$43.87B+16.8%
- 2023$37.54B+17.5%
- 2022$31.96B+27.9%
- 2021$24.98B+17.2%
- 2020$21.32B+9.5%
- 2019$19.46B+13.5%
- 2018$17.15B-5.5%
- 2017$18.15B-3.9%
- 2016$18.88B-5.9%
- 2015$20.06B-3.1%
- 2014$20.70B+0.8%
- 2013$20.55B-9.0%
- 2012$22.58B-18.1%
- 2011$27.57B+2.5%
- 2010$26.88B-0.6%
- 2009$27.03B+8.1%
- 2008$25.00B+8.1%
- 2007$23.14B+10.6%
- 2006$20.92B+12.5%
- 2005$18.59B+14.5%
- 2004$16.23B+12.8%
- 2003$14.39B+8.0%
- 2002$13.32B+10.8%
- 2001$12.02B-33.6%
- 2000$18.12B+52.4%
- 1999$11.89B+28.0%
- 1998$9.29B—
- 1997$0.00—
- 1996$0.00—
- 1995$0.00—
- 1994$0.00—
- 1993$0.00—
- 1992$0.00—
- 1991$0.00—
- 1990$0.00—
Gross Profit values are taken from AstraZeneca's reported income statements (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's current gross profit (TTM) is $49.37B. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, AstraZeneca (AZN) gross profit totalled $48.11B – grew 9.7% year-over-year.
Looking at the 2020–2025 (5 years) stretch, AstraZeneca gross profit compounded at +17.7% per year, sustaining 7 straight years of year-over-year growth.
The record annual gross profit stands at $48.11B, reached in 2025; the historical low of $0.00 was recorded in 1990.
AstraZeneca Gross Profit by Year
AstraZeneca Gross Profit 2025: $48.11B
2025's gross profit for AstraZeneca came in at $48.11B, grew 9.7% from 2024. This figure represents the highest annual value in the available history.
AstraZeneca Gross Profit 2024: $43.87B
AstraZeneca posted gross profit of $43.87B in 2024, grew 16.8% from 2023.
AstraZeneca Gross Profit 2023: $37.54B
In 2023, AstraZeneca reported gross profit of $37.54B, grew 17.5% from 2022.
AstraZeneca Gross Profit 2022: $31.96B
AstraZeneca gross profit in 2022 was $31.96B, grew 27.9% from 2021.
AstraZeneca Gross Profit 2021: $24.98B
AstraZeneca gross profit in 2021 was $24.98B.
See more financial history for AstraZeneca (AZN).
Sector peers by Gross Profit
Healthcare peers of AstraZeneca (AZN), ranked by their latest gross profit
| $82.92B | |
| $68.56B | |
| $54.62B | |
| $46.73B | |
| $42.96B | |
| $39.01B | |
| $26.01B | |
| $16.78B |
- $82.92B
- $68.56B
- $54.62B
- $46.73B
- $42.96B
- $39.01B
- $26.01B
Frequently asked questions
AstraZeneca (AZN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation